Photo

The GE Venue 40 series

GE Healthcare is presenting its new Venue ultrasound product line at Medica. The Venue 40, the first product launched, provides visualisation for needle guidance procedures and rapid diagnostics in real-time at the bedside. These point-of-care (POC) settings are the fastest growing in ultrasound internationally (USA growth: 30% average in the last four years. Source: industry report by Klein…

Photo

MIRROR 2

Mirror 2, the all-digital colour Doppler ultrasound system, produced by Landwind International Medical Science Pte Ltd, incorporates a number of advanced imaging technologies, including powerful multi-beam parallel imaging, premium vascular imaging, real-time dynamic receiving focusing, magic focus, superior aptitude filter, 3-D, and panoramic imaging, the manufacturer reports.

Photo

The Epidot SC

Founded in Poland, in 1993, Echo-Son S.A. manufactures the ultrasound colour Doppler scanners Spinel II, Epidot_SC, Desmin_M, Epidot_V and the portable (b/w) Desmin_F, Desmin_H and Albit, for medical and veterinary applications (2.5-12.0 MHz, Doppler) and ophthalmology: A+B mode scanner 12 MHz and pachymeter 20MHz.

Molecular imaging of cancer

Molecular-genetic imaging in living organisms has experienced exceptional growth over the past 10 years, and can be defined as „the macroscopic visualization of cellular processes in space and time at the molecular level of function”.

Photo

The Fetatrack DD250

Weighing just 2 KG, in a hospital, small clinic or doctor’s surgery the fully portable Fetatrack DD250 can provide continuous foetal and vascular dopler. The unit operates from a mains electricity supply for 30 hours; alternatively the built-in rechargable batteries can be used. ‘The system has all the necessary facilities for accurate antenatal foetal assessment in one compact unit,’…

Photo

PET-CT vs. whole-body MRI

For many indications, because PET-CT produces a very high accuracy for many tumours, this modality is the gold standard, Prof. Reiser confirmed. It also enables good observation of the course of the disease. After an injection of radioactive tracers we can visualise increased metabolic activity in great detail and with high sensitivity. This is an increasingly important issue not only in primary…

Photo

An affair of the heart

The heart of cardiac radiology set the rhythm for this October's 10th Annual Meeting of the European Society of Cardiac Radiology (ESCR) in Leipzig, when state-of-the art technology and progress in cardiac imaging were introduced alongside an educational programme that catered for experienced as well as novice cardiac radiologists

Expanding your diagnostic imaging services?

If you need to expand your diagnostic imaging services and a fixed installation is too costly but a mobile solution cannot cover your demand, Alliance Medical, Europe's largest provider of out-sourced diagnostic imaging services, reports that it could become your partner. "Did you ever think about a semi-static installation?" the company asks. "The services we can offer by far exceed the…

Photo

The brain - A promising target for multimodal imaging

Integrated PET/MRI systems will permit the simultaneous acquisition of molecular, functional and structural parameters. The combined strengths of PET (high sensitivity and specificity, but relatively low spatial resolution) and MRI (high resolution, but low sensitivity) is the most attractive feature of multimodal imaging with hybrid scanners. Their application could substantially contribute to…

Safeguarding the future of MRI

Europe holds a leading position in the research and development of MRI, which has been used for over 25 years, imaging up to 500 million patients without evidence of harm to workers due to EMF exposure. It is also well known that MRI is free from health risks associated with ionising radiation such as X-rays, in many situations the alternative to MRI

Imaging Crucial for personalized medicine

'Personalized medicine' -- where therapy is designed for the individual patient -- is a popular concept in healthcare today, but according to a new market research report, it will be driven by the imaging industry, especially the new molecular technologies. If images can reveal not just the heightened metabolic activity characteristic of tumors but the tumors' chemical signatures, physicians can…

916 show more articles
Subscribe to Newsletter